Skip to main content

letter

. 1992 Sep 26;305(6856):768–771. doi: 10.1136/bmj.305.6856.768-b

Antenatal screening for Down's syndrome.

V J Macri, R Clark

PMCID: PMC1883382 PMID: 1422338

768

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Macri J. N., Kasturi R. V., Krantz D. A., Cook E. J., Moore N. D., Young J. A., Romero K., Larsen J. W., Jr Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1248–1253. doi: 10.1016/0002-9378(90)90700-h. [DOI] [PubMed] [Google Scholar]
Prenatal screening for Down's syndrome. BMJ. 1991 Aug 24;303(6800):468–469. [PMC free article] [PubMed] [Google Scholar]
Spencer K., Carpenter P. Risk of Down's syndrome and amniocentesis rate. BMJ. 1992 Mar 7;304(6827):640–641. doi: 10.1136/bmj.304.6827.640-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
Spencer K., Macri J. N. Early detection of Down's syndrome using free beta human choriogonadotropin. Ann Clin Biochem. 1992 May;29(Pt 3):349–350. doi: 10.1177/000456329202900319. [DOI] [PubMed] [Google Scholar]
Wald N. J., Kennard A., Densem J. W., Cuckle H. S., Chard T., Butler L. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ. 1992 Aug 15;305(6850):391–394. doi: 10.1136/bmj.305.6850.391. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES